Increased access to emergency contraception: why it may fail
- PMID: 19095666
- PMCID: PMC2721726
- DOI: 10.1093/humrep/den460
Increased access to emergency contraception: why it may fail
Abstract
Background: To explore why increased access to emergency contraception (EC) failed to reduce pregnancies in a recent randomized controlled trial.
Methods: We used multivariable logistic regression to identify risk factors for unintended pregnancy using data from a trial involving sexually active women (n = 1490, aged 14-24 years) randomly assigned to either increased access or standard access to EC. We used predictive modeling to generate estimated pregnancy risk scores for each participant. We then examined EC use among women at low or high baseline risk of pregnancy.
Results: Gravidity, recent history of unprotected sex (within 14 days of enrollment to study) and lower aversion to pregnancy predicted unintended pregnancy. Women in the increased access group were more likely than women in the standard access group to use EC repeatedly. This difference was significantly stronger (P = 0.03) among low risk women than high risk women [Relative risk (RR) 10.0, 95% confidence interval (CI) 6.5-15.4 and RR 5.5, 95% CI 3.8-7.9, respectively].
Conclusions: Increased access to EC had a greater impact on women who were at lower baseline risk of pregnancy. This may explain in part why increased access to EC has had no measurable benefit in clinical trials.
Figures
References
-
- Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health. 2006;38:90–96. - PubMed
-
- Hu X, Cheng L, Hua X, Glasier A. Advanced provision of emergency contraception to postnatal women in China makes no difference in abortion rates: a randomized controlled trial. Contraception. 2005;72:111–116. - PubMed
-
- Lo SS, Fan SY, Ho PC, Glasier AF. Effect of advanced provision of emergency contraception on women's contraceptive behavior: a randomized controlled trial. Hum Reprod. 2004;19:2404–2410. - PubMed
-
- Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191–1194. - PubMed